Conversion Study to Optimize Immunosuppressive Regimen by Withdrawal of Steroids, Cyclosporine A Dose Reduction and a Switch to Mycophenolate mofetil for Patients After Heart Transplantation in the Long-Term.

Trial Profile

Conversion Study to Optimize Immunosuppressive Regimen by Withdrawal of Steroids, Cyclosporine A Dose Reduction and a Switch to Mycophenolate mofetil for Patients After Heart Transplantation in the Long-Term.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs Ciclosporin; Mycophenolate mofetil
  • Indications Heart transplant rejection
  • Focus Adverse reactions
  • Most Recent Events

    • 08 Sep 2008 Actual patient number (40) added as reported by ClinicalTrials.gov.
    • 08 Sep 2008 Actual end date (Jun 2008) added as reported by ClinicalTrials.gov.
    • 08 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top